Patent · US Active

DPP IV inhibitor formulations

US12178819B2 · kind B2 · utility

0Cited by

167References

20Claims

0Family size

Assignee

Boehringer Ingelheim International GmbH · DE

Inventors

Anja Kohlrausch · Biberach, DE
Patrick ROMER · Jüterbog, DE
Gerd SEIFFERT · Laupheim, DE

Key dates

Filing date	May 13, 2021
Grant date	Dec 31, 2024
Priority date	—
Expiry date	May 13, 2041

Classification

Technology area (CPC A)Human Necessities
CPC primaryA61K9/2077
WIPO fieldPharmaceuticals
WIPO sectorChemistry

Abstract

The present invention relates to pharmaceutical compositions of DPP IV inhibitors with an amino group, their preparation and their use to treat diabetes mellitus.

Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.